hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Pharma Companies Need to Keep Improving AIDS Response, Says ICCR and Nigerian Doctor

Author: William Baue, SocialFunds, Published on: 1 December 2006

In August 2006, the Interfaith Center on Corporate Responsibility (ICCR) produced the most thorough study of pharmaceutical company action on HIV/AIDS, documenting how the industry falls significantly short of best practice...The Business and Human Rights Resource Centre posted the report along with company responses to it on its website. [The following companies sent responses: Abbott Laboratories; AstraZeneca; GlaxoSmithKline; Boehringer-Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Tibotec (part of Johnson & Johnson), Wyeth. The following did not respond: Eli Lilly; Gilead Sciences; Hoffman-La Roche; sanofi-aventis; Schering-Plough.]...[The Resource Centre] recently added a paper by Dr. Chukwumuanya Igboekwu...of Physicians for Social Justice (PSJ) in Nigeria...in which he identifies patent protection...as a persisting problem in pharma companies' response to AIDS...Dr. Igboekwu cites the case of Novartis filing a lawsuit in India to protect patents covering certain of its cancer drugs...The...Resource Centre posted a response...from Novartis...

Read the full post here

Related companies: Abbott Laboratories AstraZeneca Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly Gilead Sciences GlaxoSmithKline Hoffmann-La Roche (part of Roche) Johnson & Johnson Novartis Pfizer Sanofi Schering-Plough Tibotec (part of Johnson & Johnson)